Your prediction
Pros and Cons of Taro Pharmaceutical Industries Ltd in the next few years
Pros
?
B****
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
S********** s********
?
C******** o* t** e**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Taro Pharmaceutical Industries Ltd vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Taro Pharmaceutical Industries Ltd | - | - | - | - | - | - | - |
| Repligen Corp. | -0.790% | -2.788% | 9.325% | -6.894% | -1.572% | -16.404% | -7.798% |
| Opko Health Inc. | 0.320% | 2.198% | 3.305% | -24.887% | -18.992% | -4.140% | -70.487% |
| Amicus Therapeutics Inc. | -0.600% | -1.190% | 4.403% | -13.089% | -9.290% | -24.145% | -54.144% |
Comments
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.
Show more
Ratings data for TARO provided by MarketBeat
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.
Show more
Ratings data for TARO provided by MarketBeat
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.
Show more
Ratings data for TARO provided by MarketBeat